Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study (Q27851528)
Jump to navigation
Jump to search
scientific article
- Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study |
scientific article |
|
Statements
1 reference
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study (English)
1 reference
Gini F Fleming
1 reference
Michael W Sill
1 reference
Kathleen M Darcy
1 reference
D Scott McMeekin
1 reference
J Tate Thigpen
1 reference
Lisa M Adler
1 reference
Jonathan S Berek
1 reference
Julia A Chapman
1 reference
Paul A DiSilvestro
1 reference
Ira R Horowitz
1 reference
James V Fiorica
1 reference
18 October 2009
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference